Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,250 | 1 | 55.5% |
| Travel and Lodging | $2,011 | 6 | 17.8% |
| Honoraria | $1,750 | 1 | 15.5% |
| Food and Beverage | $1,056 | 18 | 9.4% |
| Education | $198.95 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $10,403 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $218.19 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $165.75 | 3 | $0 (2024) |
| Incyte Corporation | $126.04 | 1 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $106.92 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 | $0 (2021) |
| ABBVIE INC. | $83.95 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $42.11 | 2 | $0 (2024) |
| Seagen Inc. | $19.23 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,368 | 18 | Exelixis Inc. ($4,153) |
| 2023 | $6,730 | 7 | Exelixis Inc. ($6,250) |
| 2022 | $67.13 | 2 | Janssen Biotech, Inc. ($47.90) |
| 2021 | $99.95 | 1 | SANOFI-AVENTIS U.S. LLC ($99.95) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $101.79 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Oncology | ||||||
| 10/04/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/03/2024 | Exelixis Inc. | CABOMETYX (Drug) | Honoraria | Cash or cash equivalent | $1,750.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $439.95 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $439.95 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $350.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $350.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $215.46 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $215.46 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $55.28 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 06/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $55.28 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 05/04/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $106.92 | General |
| Category: Oncology | ||||||
| 04/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 11/09/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $117.41 | General |
| 10/20/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/18/2023 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $126.04 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $100.78 | General |
| Category: Oncology | ||||||
| 04/21/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/08/2023 | Exelixis Inc. | — | Consulting Fee | Cash or cash equivalent | $6,250.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 100 | 199 | $61,629 | $17,207 |
| 2022 | 2 | 86 | 227 | $70,729 | $21,610 |
| 2021 | 2 | 102 | 172 | $51,180 | $15,855 |
| 2020 | 1 | 83 | 135 | $32,085 | $7,275 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 78 | 176 | $56,224 | $15,781 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $2,585 | $713.35 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $2,820 | $713.35 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 72 | 212 | $67,204 | $20,676 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 15 | $3,525 | $933.90 | 26.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 65 | 128 | $40,720 | $13,045 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 44 | $10,460 | $2,810 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 68 | 114 | $27,150 | $6,102 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 21 | $4,935 | $1,173 | 23.8% |
About Nakia Brooks, PHYSICIAN ASSISTANT
Nakia Brooks, PHYSICIAN ASSISTANT is a Physician Assistant healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013187301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nakia Brooks, PHYSICIAN ASSISTANT has received a total of $11,265 in payments from pharmaceutical and medical device companies, with $4,368 received in 2024. These payments were reported across 28 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($6,250).
As a Medicare-enrolled provider, Brooks has provided services to 371 Medicare beneficiaries, totaling 733 services with total Medicare billing of $61,947. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location New Orleans, LA
- Active Since 03/03/2008
- Last Updated 09/19/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1013187301
Products in Payments
- CABOMETYX (Drug) $4,153
- PEMAZYRE (Drug) $126.04
- ERLEADA (Drug) $117.85
- Onivyde (Drug) $106.92
- IMFINZI (Biological) $100.78
- JEVTANA (Drug) $99.95
- CREON (Drug) $83.95
- DARZALEX (Biological) $47.90
- Enhertu (Drug) $42.11
- PADCEV (Biological) $19.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in New Orleans
Claire Darre, Pa-C, PA-C
Physician Assistant — Payments: $49,989
Jennifer Scheuermann, Pa-C, PA-C
Physician Assistant — Payments: $47,210
David G'sell, Pa, PA
Physician Assistant — Payments: $25,618
Elizabeth Clement
Physician Assistant — Payments: $17,319
Sydney Tsen, Pa-C, PA-C
Physician Assistant — Payments: $12,526
Richard Tubbs, Phd,Pa-C, PHD,PA-C
Physician Assistant — Payments: $9,466